IP Library › Granted Patent US 12,540,252
Granted Patent B2
US 12,540,252 · App. 18/279,516 · Granted Feb 3, 2026

Active energy ray-curable inkjet ink, and printed matter

Inventors: Takumi Yoshikawa (Tokyo, JP); Gosuke Kikutsuji (Tokyo, JP)
Assignees: Artience Co., Ltd.; TOYOCOLOR CO., LTD.
C09D11/322B41J2/01B41J2/2107B41M5/00C09D11/101C09D11/32C09D11/38
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,540,252
App. No.
18/279,516
Granted
Feb 3, 2026
Kind
B2
Abstract

Provided is an active energy ray-curable inkjet ink containing: C. I. Pigment Yellow 150; an active energy ray-polymerizable compound (A-1) including multiple ethylene oxide groups and a specific structure; an acylphosphine oxide initiator (B-1); and a siloxane surfactant (C-1) having a weight-average molecular weight of 400 to 20,000, wherein a total amount of a compound represented by general formula 2 below is 100 ppm or less. In general formula 2, R 2 and R 3 each independently represent an amino group or a hydroxyl group. General formula 2:

Claims (14)

1 . An active energy ray-curable inkjet ink comprising: C. I. Pigment Yellow 150; an active energy ray-polymerizable compound (A); a photopolymerization initiator (B); and a surfactant (C), wherein

the active energy ray-polymerizable compound (A) contains a compound (A-1) represented by general formula 1,

the photopolymerization initiator (B) contains an acylphosphine oxide initiator (B-1),

the surfactant (C) contains a siloxane surfactant (C-1) having a weight-average molecular weight of 400 to 20,000,

the active energy ray-curable inkjet ink contains or does not contain a monofunctional monomer, and when the active energy ray-curable inkjet ink contains the monofunctional monomer, a total amount of 85% by mass or less relative to a total amount of the compound (A-1), and

a total amount of a compound represented by general formula 2 below contained in the active energy ray-curable inkjet ink is 100 ppm or less,

CH 2 ═CH—CO—(O—CH 2 CH 2 ) n —O—R 1   General formula 1

wherein, R 1 represents an acryloyl group or a vinyl group, and n represents an integer of 2 to 10,

General formula 2:

wherein, R 2 and R 3 each independently represent an amino group or a hydroxyl group.

2 . The active energy ray-curable inkjet ink according to claim 1 , wherein the active energy ray-polymerizable compound (A) further contains a compound (A-2) selected from the group consisting of polypropylene glycol di(meth)acrylate and alkanediol di(meth)acrylate.

3 . The active energy ray-curable inkjet ink according to claim 1 , wherein an amount of the compound (A-1) represented by general formula 1 is 10 to 90% by mass of a total amount of the active energy ray-curable inkjet ink.

4 . The active energy ray-curable inkjet ink according to claim 2 , wherein an amount of the compound (A-1) represented by general formula 1 is 10 to 90% by mass of a total amount of the active energy ray-curable inkjet ink.

5 . A printed matter obtained using the active energy ray-curable inkjet ink according to claim 1 .

Assignments (2)
CHANGE OF NAME Recorded Mar 7, 2024
From: TOYO INK SC HOLDINGS CO., LTD
To: ARTIENCE CO., LTD.
Reel/Frame 066763/0256 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 1, 2023
From: YOSHIKAWA, TAKUMI; KIKUTSUJI, GOSUKE
To: TOYO INK SC HOLDINGS CO., LTD.; TOYOCOLOR CO., LTD.
Reel/Frame 064777/0759 →
Priority Claims (1)
JP 2021-192636 · Nov 29, 2021 · national
Continuity (1)
Related Publication 20240166902A1 · May 23, 2024
References Cited (40)
US 8646901B2 · De Meutter et al. · 2014 [cited by applicant]
US 10526499B2 · Saito · 2020 [cited by applicant]
US 20060004116A1 · Kishi · 2006 [cited by examiner]
US 20070064050A1 · Ohkubo · 2007 [cited by examiner]
US 20090136680A1 · Kishi · 2009 [cited by examiner]
US 20110001779A1 · Kida · 2011 [cited by examiner]
US 20110242191A1 · Mochizuki · 2011 [cited by examiner]
US 20140104356A1 · Kitade · 2014 [cited by applicant]
US 20140275319A1 · Yamada et al. · 2014 [cited by applicant]
US 20150130878A1 · Kohzuki · 2015 [cited by examiner]
US 20180079921A1 · Okamoto et al. · 2018 [cited by applicant]
US 20190062580A1 · Nakashima et al. · 2019 [cited by applicant]
US 20190085190A1 · De Meutter · 2019 [cited by applicant]
US 20210214568A1 · Konda · 2021 [cited by examiner]
US 20220119662A1 · Retailleau · 2022 [cited by examiner]
US 20230102004A1 · Kikutsuji · 2023 [cited by examiner]
JP 5852361A · 1983 [cited by applicant]
JP 2000119544A · 2000 [cited by applicant]
JP 2006282758A · 2006 [cited by applicant]
JP 2011195694A · 2011 [cited by applicant]
JP 2013053208A · 2013 [cited by applicant]
JP 2013514904A · 2013 [cited by applicant]
JP 2014070135A · 2014 [cited by applicant]
JP 2014210871A · 2014 [cited by applicant]
JP 2015168723A · 2015 [cited by applicant]
JP 2015183147A · 2015 [cited by applicant]
JP 2017095531A · 2017 [cited by applicant]
JP 2017155190A · 2017 [cited by applicant]
JP 2019089961A · 2019 [cited by applicant]
JP 2022149204A · 2022 [cited by applicant]
WO 2012172973A1 · 2012 [cited by applicant]
WO 2013062090A1 · 2013 [cited by applicant]
WO 2017145671A1 · 2017 [cited by applicant]
WO 2017188003A1 · 2017 [cited by applicant]
WO 2020152037A1 · 2020 [cited by applicant]
Extended European Search Report issued Feb. 24, 2025 in Application No. 22898233.6. [cited by applicant]
Japanese Office Action of JP 2022-162047 dated Feb. 28, 2023. [cited by applicant]
International Search Report of PCT/JP2022/036933 dated Dec. 20, 2022. [cited by applicant]
Written opinion of PCT/JP2022/036933 dated Dec. 20, 2022. [cited by applicant]
Communication issued Nov. 17, 2025 in EP Application No. 22898223.6. [cited by applicant]